These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 19431076
21. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU. Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737 [Abstract] [Full Text] [Related]
22. Age-related macular degeneration: a perspective on genetic studies. Patel N, Adewoyin T, Chong NV. Eye (Lond); 2008 Jun 01; 22(6):768-76. PubMed ID: 17491602 [Abstract] [Full Text] [Related]
23. An update on the genetics of age-related macular degeneration. Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH. Mol Vis; 2007 Feb 07; 13():196-205. PubMed ID: 17327825 [Abstract] [Full Text] [Related]
24. Molecular genetics of AMD and current animal models. Edwards AO, Malek G. Angiogenesis; 2007 Feb 07; 10(2):119-32. PubMed ID: 17372852 [Abstract] [Full Text] [Related]
25. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Schmidt S, Haines JL, Postel EA, Agarwal A, Kwan SY, Gilbert JR, Pericak-Vance MA, Scott WK. Mol Vis; 2005 Nov 04; 11():941-9. PubMed ID: 16288198 [Abstract] [Full Text] [Related]
26. Age-related macular degeneration: diagnosis and management. Cook HL, Patel PJ, Tufail A. Br Med Bull; 2008 Nov 04; 85():127-49. PubMed ID: 18334518 [Abstract] [Full Text] [Related]
27. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Chakravarthy U, Augood C, Bentham GC, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J, Young IS, Fletcher AE. Ophthalmology; 2007 Jun 04; 114(6):1157-63. PubMed ID: 17337063 [Abstract] [Full Text] [Related]
32. Immunopathological aspects of age-related macular degeneration. Patel M, Chan CC. Semin Immunopathol; 2008 Apr 04; 30(2):97-110. PubMed ID: 18299834 [Abstract] [Full Text] [Related]
33. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration. Bora NS, Matta B, Lyzogubov VV, Bora PS. Mol Immunol; 2015 Feb 04; 63(2):176-83. PubMed ID: 25074023 [Abstract] [Full Text] [Related]
34. Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. Cheung CM, Wong TY. J Intern Med; 2014 Aug 04; 276(2):140-53. PubMed ID: 24581182 [Abstract] [Full Text] [Related]
35. Age-related macular degeneration. Khandhadia S, Cherry J, Lotery AJ. Adv Exp Med Biol; 2012 Aug 04; 724():15-36. PubMed ID: 22411231 [Abstract] [Full Text] [Related]
36. Inflammatory biomarkers for AMD. Stanton CM, Wright AF. Adv Exp Med Biol; 2014 Aug 04; 801():251-7. PubMed ID: 24664705 [Abstract] [Full Text] [Related]
37. Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration. Cooke Bailey JN, Pericak-Vance MA, Haines JL. Cold Spring Harb Perspect Med; 2014 Sep 11; 4(12):a017186. PubMed ID: 25213188 [Abstract] [Full Text] [Related]
38. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment. Geerlings MJ, de Jong EK, den Hollander AI. Mol Immunol; 2017 Apr 11; 84():65-76. PubMed ID: 27939104 [Abstract] [Full Text] [Related]